UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 安定した慢性閉塞性肺疾患（COPD）のマネージメント management of stable chronic obstructive pulmonary disease
- 2. 青年や成人の中等度持続型喘息の治療 treatment of moderate persistent asthma in adolescents and adults
- 3. 12歳未満の小児における慢性喘息：持続性喘息の治療およびコントロール薬 asthma in children younger than 12 years treatment of persistent asthma with controller medications
- 4. 喘息におけるβ刺激剤：長期使用に関する議論 beta agonists in asthma controversy regarding chronic use
- 5. 青年や成人の間欠型喘息および軽症持続型喘息の治療 treatment of intermittent and mild persistent asthma in adolescents and adults
English Journal
- Replacement of SFC-DPI with SFC-MDI exhaled through the nose improves eosinophilic chronic rhinosinusitis in patients with bronchial asthma.
- Kobayashi Y, Asako M, Yamamoto T, Yasuba H, Tomoda K, Kanda A.
- International journal of clinical pharmacology and therapeutics.Int J Clin Pharmacol Ther.2017 Jan;55 (2017)(1):89-94.
- OBJECTIVE: Eosinophilic chronic rhinosinusitis (ECRS), a subgroup of chronic rhinosinusitis with nasal polyps, is a refractory disease closely associated with bronchial asthma. We recently reported on the efficacy of ultra-fine particle inhaled corticosteroids (ICS) (hydrofluoroalkane-134a-beclometh
- PMID 27879191
- Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis.
- Vogelmeier C1, Zhong N2, Humphries MJ3, Mezzi K4, Fogel R5, Bader G4, Patalano F4, Banerji D5.
- International journal of chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis.2016 Dec 14;11:3189-3197. doi: 10.2147/COPD.S116786. eCollection 2016.
- BACKGROUND: Indacaterol/glycopyrronium (IND/GLY) is approved for maintenance treatment of adult patients with COPD. This post hoc analysis explored the efficacy and safety of IND/GLY versus salmeterol/fluticasone (SFC) in symptomatic (Global Initiative for Chronic Obstructive Lung Disease [GOLD] B a
- PMID 28008244
- Efficacy of tiotropium-olodaterol fixed-dose combination in COPD.
- Derom E1, Brusselle GG1, Joos GF1.
- International journal of chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis.2016 Dec 13;11:3163-3177. doi: 10.2147/COPD.S92840. eCollection 2016.
- Tiotropium-olodaterol, formulated in the Respimat soft-mist inhaler, is an inhaled fixed-dose combination (FDC) of a long-acting muscarinic antagonist (LAMA) and a long-acting β2-agonist (LABA), commercialized under the name of Spiolto or Stiolto. The efficacy of tiotropium-olodaterol 5-5 μg once
- PMID 28008243
Japanese Journal
- サルメテロール/フルチカゾンプロピオン酸エステル配合剤を導入した小児気管支喘息患者の特徴と有用性
- 佐々木 渓円,柳田 紀之,富川 盛光,飯倉 克人,佐藤 さくら,海老澤 元宏
- 日本小児アレルギー学会誌 29(1), 123-131, 2015
- サルメテロール/フルチカゾンプロピオン酸エステル配合剤（SFC）の適応と判断した気管支喘息患児について，その導入目的と治療効果を後方視的に検討した．対象は，2011年10月から12月にSFCを処方された62例（男児43例，女児19例）とした．SFCの導入時の年齢は，中央値11歳であった．フルチカゾンプロピオン酸エステルあるいはベクロメタゾンプロピオン酸エステルからICS力価として等量でSFCに変更 …
- NAID 130005074492
- P-303 新規診断されたCOPD症例におけるSalmeterol/Fluticasone短期治療による効果検討(成人喘息 COPD合併,口演42,第26回日本アレルギー学会春季臨床大会)
- 橋本 直純,大須賀 さと子,松崎 明日香,楠瀬 公章,横井 香平,長谷川 好規
- アレルギー 63(3・4), 618, 2014-04-05
- NAID 110009848465
Related Links
- The combination of fluticasone and salmeterol comes as a powder to inhale by mouth using a specially designed inhaler. It is usually used twice a day, in the morning and evening, about 12 hours apart. Use fluticasone ...
- Fluticasone/salmeterol inhaler should be used to treat asthma only if your asthma is not well controlled while you are using a certain long-term asthma-control medicine (eg, inhaled corticosteroid) or if you have severe asthma ...
Related Pictures
★リンクテーブル★
| リンク元 | 「ADVAIR」 |